Yang S W, Lin L J, Cordell G A, Wang P, Corley D G
Program for Collaborative Research in the Pharmaceutical Sciences, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
J Nat Prod. 1999 Nov;62(11):1551-3. doi: 10.1021/np990261q.
The feeding of (13)C- and (2)H-enriched methionine to Streptomyces staurosporeus established that the methyl carbon and proton source of both the 3'-O- and 4'-N-methyl groups of staurosporine (1) was methionine and that all three methyl protons from methionine were retained on 1. In the presence of the methyltransferase inhibitor, sinefungin, the biosynthesis of staurosporine was blocked at the last step, O-methylation. An intermediate, 3'-demethoxy-3'-hydroxystaurosporine (2), was efficiently accumulated in the medium. Other general methyltransferase inhibitors failed to produce any other staurosporine intermediates or analogues.
向星状孢链霉菌投喂富含¹³C和²H的甲硫氨酸,结果表明,星形孢菌素(1)的3'-O-甲基和4'-N-甲基的甲基碳和质子来源均为甲硫氨酸,且甲硫氨酸的所有三个甲基质子都保留在1上。在甲基转移酶抑制剂西奈芬净存在的情况下,星形孢菌素的生物合成在最后一步O-甲基化处被阻断。一种中间体,3'-去甲氧基-3'-羟基星形孢菌素(2),在培养基中有效积累。其他通用甲基转移酶抑制剂未能产生任何其他星形孢菌素中间体或类似物。